Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials.

Clin Drug Investig · 2022 · PMC9427911 · PMID 35864302

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

There were no significant differences to dimenhydrinate 40 mg (LSM [95% CI] − 0.96 [− 1.07; − 0.84]) and betahistine dihydrochloride 16 mg (LSM [95% CI] − 0.88 [− 0.95; − 0.80]), but highly significant differences to all other comparators ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.